TGFB1 and colorectal neoplasm: Considering that a significant proportion of colorectal tumours have inactivating mutations in the TGF‐β pathway, the effect of TGF‐β is unlikely to be directed to cancer cells and is more likely to influence the stroma (Cancer Genome Atlas Network, 2012).